Track 10 : Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics is the study of the impact that order plays in medication response. Its name is a reflection of the blending of genetics and medicine. Pharmacogenomics examines how a person's genetic make-up influences how they respond to drugs.

Pharmacoproteomics is a rapidly developing discipline where genetics approaches are used to create pharmacological drugs. Personalized medicine is important in this area of research. Genetics is the full complement of proteins that an organism or tissue expresses at a given moment and under certain conditions. The whole collection of proteins used in the study will serve as a substitute for significantly more sophisticated pharmacodynamics assays at a lower cost in terms of time, financial output, and clinical risk.

  • Enzymatic metabolizers of drugs
  • Implementation of clinical prediction
  • Polypharmacy

 


 


    Related Conference of Track 10 : Pharmacogenomics & Pharmacoproteomics

    October 24-25, 2024

    8th International Conference on Protein Engineering

    Zurich, Switzerland

    Track 10 : Pharmacogenomics & Pharmacoproteomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in